G. Lopez‐Berestein
- Co-authors
- Bülent ÖzpolatAnil K. SoodDavid R. LukeKiumars VadieiR. L. JulianoKapil MehtaMichael G. RosenblumE. M. Hersh
- Topics
- RNA Interference and Gene Delivery (8 papers)Nanoparticle-Based Drug Delivery (4 papers)DNA and Nucleic Acid Chemistry (4 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
G. Lopez‐Berestein
36 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Biology 548
- Infectious Diseases 267
- Oncology 222
- Epidemiology 195
- Immunology 178
Countries citing papers authored by G. Lopez‐Berestein
This map shows the geographic impact of G. Lopez‐Berestein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Lopez‐Berestein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Lopez‐Berestein more than expected).
Fields of papers citing papers by G. Lopez‐Berestein
This network shows the impact of papers produced by G. Lopez‐Berestein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Lopez‐Berestein. The network helps show where G. Lopez‐Berestein may publish in the future.
Co-authorship network of co-authors of G. Lopez‐Berestein
This figure shows the co-authorship network connecting the top 25 collaborators of G. Lopez‐Berestein. A scholar is included among the top collaborators of G. Lopez‐Berestein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Lopez‐Berestein. G. Lopez‐Berestein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | The RNA-binding protein LARP1 is a cancer therapeutic target | 1 |
| 4 | 26 | |
| 5 | 2 | |
| 6 | 177 | |
| 7 | 28 | |
| 8 | 1 | |
| 9 | 32 | |
| 10 | 33 | |
| 11 | 21 | |
| 12 | 57 | |
| 13 | Antisense oligonucleotides and carriers for gene therapy | 4 |
| 14 | 88 | |
| 15 | 7 | |
| 16 | Tumor necrosis factor and c-fos expression in human peripheral-blood monocytes: expression is dependent on stage of in vitro differentiation. | 1 |
| 17 | 69 | |
| 18 | Prospects for liposomes as a novel drug delivery system | 0 |
| 19 | New lives for old drugs: Liposomal drug delivery systems reduce the toxicity but not the potency of certain chemotherapeutic agents | 7 |
| 20 | Tumor cytotoxicity of human peripheral blood monocytes activated by muramyl dipeptide analogues | 1 |
About G. Lopez‐Berestein
G. Lopez‐Berestein is a scholar working on Transplantation, Hematology and Biomaterials, having authored 38 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (8 papers), Nanoparticle-Based Drug Delivery (4 papers) and DNA and Nucleic Acid Chemistry (4 papers). The work is most often cited by research in Infectious Diseases (267 citations), Biomaterials (150 citations) and Pharmaceutical Science (59 citations). G. Lopez‐Berestein has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Bülent Özpolat, Anil K. Sood, David R. Luke, Kiumars Vadiei, R. L. Juliano, Kapil Mehta, Michael G. Rosenblum, E. M. Hersh, James M. Reuben and M. P. Sullivan. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.